Massachusetts Financial Services Co. MA Has $8.53 Million Stake in Sanofi (NASDAQ:SNY)

Massachusetts Financial Services Co. MA lifted its stake in shares of Sanofi (NASDAQ:SNY) by 4.8% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 147,955 shares of the company’s stock after acquiring an additional 6,796 shares during the period. Massachusetts Financial Services Co. MA’s holdings in Sanofi were worth $8,527,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. POM Investment Strategies LLC acquired a new stake in Sanofi in the second quarter valued at approximately $25,000. Northwest Investment Counselors LLC bought a new position in shares of Sanofi in the 3rd quarter worth $29,000. Concord Wealth Partners grew its position in Sanofi by 157.8% in the 3rd quarter. Concord Wealth Partners now owns 593 shares of the company’s stock valued at $34,000 after purchasing an additional 363 shares during the period. Arrow Financial Corp bought a new stake in Sanofi during the 2nd quarter valued at $35,000. Finally, Fortitude Family Office LLC raised its holdings in Sanofi by 708.6% during the third quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock worth $43,000 after buying an additional 659 shares during the last quarter. 10.04% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently commented on SNY. StockNews.com downgraded shares of Sanofi from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 7th. Citigroup raised Sanofi to a “strong-buy” rating in a report on Tuesday, September 17th. Two analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $57.50.

Sanofi Stock Down 0.1 %

SNY opened at $48.28 on Wednesday. Sanofi has a fifty-two week low of $45.22 and a fifty-two week high of $58.97. The firm has a market capitalization of $122.53 billion, a P/E ratio of 24.63, a PEG ratio of 1.22 and a beta of 0.61. The company’s 50-day moving average is $53.35 and its 200 day moving average is $52.17. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.00 and a quick ratio of 0.65.

Sanofi (NASDAQ:SNY) last announced its earnings results on Friday, October 25th. The company reported $1.57 earnings per share for the quarter, topping analysts’ consensus estimates of $0.22 by $1.35. The firm had revenue of $13.44 billion for the quarter, compared to the consensus estimate of $16.59 billion. Sanofi had a return on equity of 27.45% and a net margin of 9.96%. The company’s revenue was up 12.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.55 EPS. Research analysts expect that Sanofi will post 4.29 earnings per share for the current fiscal year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.